• Myeloma UK
  • Clinical Service Excellence Programme
Top menu
Google+TwitterFacebook
Myeloma Academy
Myeloma Academy

Sign in | Register

Call us for more info on 0131 557 3332

Menu
  • Home
  • CPD & Learning
    • Myeloma Nurse Learning Programme
    • My CPD Portfolio
    • Challenging Cases
    • Tutorials
    • Seminars
    • Short Courses for Haematologists
    • Close
  • Library
    • Guidelines
      • BSH/UKMF
      • European myeloma network
      • IMWG
      • NICE
      • Close
    • Health Technology Assessment
    • Journal club
    • Patient Support and Information
      • Myeloma
      • AL amyloidosis
      • Close
    • Medical animations
    • Close
  • Resources
    • Nursing Best Practice Guides
    • Nurse role development
    • Assessment tools
    • Case reports
    • Myeloma Diagnosis Pathway
    • Myeloma Drug Finder
    • Myeloma Spotlight
    • Myeloma Trial Finder
    • Primary and secondary care education
    • RCGP Myeloma screencast
    • Close
  • News & Events
    • News
    • Event calendar
    • Meeting highlights
    • Close
  • CSEP
  • About Us
    • Contact Us
    • Close
MENU CLOSE back  

IMWG Consensus perspectives: risk factors for progression and guidelines for monitoring and management of MGUS and smouldering myeloma

In this article, members of the International Myeloma Working Group review the available data and provide new recommendations for the management of MGUS and smouldering myeloma patients.

August 11, 2014
FacebookshareTwittertweetGoogle+share
  • Guidelines
  • Health Technology Assessment (HTA) Briefing
  • Journal club
  • Patient Support and Information
  • Medical animations
Myeloma Academy
Bottom menu

Charity No: SC 026116
Myeloma UK
22 Logie Mill
Beaverbank Business Park
Edinburgh
EH7 4HG